risedronic acid has been researched along with Osteogenic Sarcoma in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteosarcoma is a highly malignant bone tumor and is the most commonly encountered malignant bone tumor in children and adolescents." | 1.35 | Risedronate inhibits human osteosarcoma cell invasion. ( Jung, ST; Kim, YK; Xin, ZF, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kolmas, J | 1 |
| Pajor, K | 1 |
| Pajchel, L | 1 |
| Przekora, A | 1 |
| Ginalska, G | 1 |
| Oledzka, E | 1 |
| Sobczak, M | 1 |
| Xin, ZF | 1 |
| Kim, YK | 1 |
| Jung, ST | 1 |
2 other studies available for risedronic acid and Osteogenic Sarcoma
| Article | Year |
|---|---|
Fabrication and physicochemical characterization of porous composite microgranules with selenium oxyanions and risedronate sodium for potential applications in bone tumors.
Topics: Alginates; Anions; Antineoplastic Agents; Bone Neoplasms; Cell Line, Tumor; Drug Carriers; Durapatit | 2017 |
Risedronate inhibits human osteosarcoma cell invasion.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Cell Line, Tumor; Cell Prol | 2009 |